Terms: = Prostate cancer AND HIST1H3B, H3_1, P68431, H3FJ, H3/j, H3FF, H3/f, H3_f, H3FK, H3F1K, H3/k, H3FH, H3/h, H3FI, H3/i, H3FD, H3/d, H3FB, H3/b, H3FC, H3/c, H3FL, H3/l, H3FA, H3/A, ENSG00000124693, 8358 AND Treatment
3 results:
1. A prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of prostate cancer in Gleason Grade Group 1: A Multicenter Retrospective Study.
Zhang J; Kang F; Gao J; Jiao J; Quan Z; Ma S; Li Y; Guo S; Li Z; Jing Y; Zhang K; Yang F; Han D; Wen W; Zhang J; Ren J; Wang J; Guo H; Qin W
J Nucl Med; 2023 Nov; 64(11):1750-1757. PubMed ID: 37652543
[TBL] [Abstract] [Full Text] [Related]
2. B7-H3, a checkpoint molecule, as a target for cancer immunotherapy.
Yang S; Wei W; Zhao Q
Int J Biol Sci; 2020; 16(11):1767-1773. PubMed ID: 32398947
[TBL] [Abstract] [Full Text] [Related]
3. Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line.
Herman-Antosiewicz A; Xiao H; Lew KL; Singh SV
Mol Cancer Ther; 2007 May; 6(5):1673-81. PubMed ID: 17513615
[TBL] [Abstract] [Full Text] [Related]
